SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001297184-20-000047
Filing Date
2020-08-07
Accepted
2020-08-07 18:32:44
Documents
93
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q amph-20200630x10q.htm   iXBRL 10-Q 2884695
2 EX-10.1 amph-20200630ex101e5af3e.htm EX-10.1 79377
3 EX-10.2 amph-20200630ex102d763a6.htm EX-10.2 209089
4 EX-31.1 amph-20200630ex311750234.htm EX-31.1 18241
5 EX-31.2 amph-20200630ex31225b98f.htm EX-31.2 16760
6 EX-32.1 amph-20200630ex321dd1370.htm EX-32.1 9547
7 EX-32.2 amph-20200630ex322123c4d.htm EX-32.2 9548
8 GRAPHIC amph-20200630ex102d763a6004.jpg GRAPHIC 2454
  Complete submission text file 0001297184-20-000047.txt   11415825

Data Files

Seq Description Document Type Size
9 EX-101.SCH amph-20200630.xsd EX-101.SCH 63884
10 EX-101.CAL amph-20200630_cal.xml EX-101.CAL 63935
11 EX-101.DEF amph-20200630_def.xml EX-101.DEF 231453
12 EX-101.LAB amph-20200630_lab.xml EX-101.LAB 488500
13 EX-101.PRE amph-20200630_pre.xml EX-101.PRE 442341
14 EXTRACTED XBRL INSTANCE DOCUMENT amph-20200630x10q_htm.xml XML 2407590
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36509 | Film No.: 201085857
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences